Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. | Blood Cancer J | 2024 | 38307865 | PubTator, text mining | PubMed |
| Decoding the mechanisms of chimeric antigen receptor (CAR) T cell-mediated killing of tumors: insights from granzyme and Fas inhibition. | Cell Death Dis | 2024 | 38307835 | PubTator, text mining | PubMed |
| T-FINDER: A highly sensitive, pan-HLA platform for functional T cell receptor and ligand discovery. | Sci Adv | 2024 | 38306432 | PubTator, text mining | PubMed |
| PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity. | J Immunother Cancer | 2024 | 38296597 | PubTator, text mining | PubMed |
| CARs are sharpening their weapons. | J Immunother Cancer | 2024 | 38296592 | PubTator, text mining | PubMed |
| Investigation on Compositional Structures of the Organic Matter and Biomarker Distributions in Shengli Lignite. | ACS Omega | 2024 | 38284082 | PubTator, text mining | PubMed |
| Long-term stability of clinical-grade lentiviral vectors for cell therapy. | Mol Ther Methods Clin Dev | 2024 | 38282894 | PubTator, text mining | PubMed |
| Natural Killer Cells and Cytotoxic T Cells: Complementary Partners against Microorganisms and Cancer. | Microorganisms | 2024 | 38276215 | PubTator, text mining | PubMed |
| CAR‑T cell therapy: A breakthrough in traditional cancer treatment strategies (Review). | Mol Med Rep | 2024 | 38275119 | PubTator, text mining | PubMed |
| Label-free-based proteomic analysis reveals differential whey proteins of porcine milk during lactation. | Food Chem X | 2024 | 38268845 | PubTator, text mining | PubMed |
| Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer. | Int J Mol Sci | 2024 | 38256268 | PubTator, text mining | PubMed |
| Molecular Targeting of the Human Epidermal Growth Factor Receptor-2 (HER2) Genes across Various Cancers. | Int J Mol Sci | 2024 | 38256137 | PubTator, text mining | PubMed |
| Current Technologies and Future Perspectives in Immunotherapy towards a Clinical Oncology Approach. | Biomedicines | 2024 | 38255322 | PubTator, text mining | PubMed |
| Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs. | Exp Hematol Oncol | 2024 | 38254219 | PubTator, text mining | PubMed |
| New facet of CARs: HBV-specific CARs as inhibitors of virus morphogenesis and release. | Gut | 2024 | 38253479 | PubTator, text mining | PubMed |
| Broadening horizons: ferroptosis as a new target for traumatic brain injury. | Burns Trauma | 2024 | 38250705 | PubTator, text mining | PubMed |
| Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth. | Nat Commun | 2024 | 38242888 | PubTator, text mining | PubMed |
| The critical role of tumor microbiome in cancer immunotherapy. | Cancer Biol Ther | 2024 | 38241173 | PubTator, text mining | PubMed |
| Chimeric Antigen Cytotoxic Receptors for In Vivo Engineering of Tumor-Targeting NK Cells. | Immunohorizons | 2024 | 38240638 | PubTator, text mining | PubMed |
| CD19 occupancy may drive CARs further. | Blood | 2024 | 38236611 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=9